Overview
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
Status:
Unknown status
Unknown status
Trial end date:
2007-12-01
2007-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage versus a low dosage.Phase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Heidelberg UniversityTreatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:- diabetic macular edema and visual acuity between 20/200 and 20/40 age over 18 years
Exclusion Criteria:
- recent treatment with laser photocoagulation or intravitreal drugs